FDMT
Price
$4.30
Change
+$0.39 (+9.97%)
Updated
Jun 6, 04:19 PM (EDT)
Capitalization
181.13M
62 days until earnings call
RGNX
Price
$9.46
Change
+$1.10 (+13.16%)
Updated
Jun 6, 04:38 PM (EDT)
Capitalization
417.84M
54 days until earnings call
Interact to see
Advertisement

FDMT vs RGNX

Header iconFDMT vs RGNX Comparison
Open Charts FDMT vs RGNXBanner chart's image
4D Molecular Therapeutics
Price$4.30
Change+$0.39 (+9.97%)
Volume$200
Capitalization181.13M
REGENXBIO
Price$9.46
Change+$1.10 (+13.16%)
Volume$2.18K
Capitalization417.84M
FDMT vs RGNX Comparison Chart
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. RGNX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a StrongBuy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (FDMT: $3.91 vs. RGNX: $8.33)
Brand notoriety: FDMT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 31% vs. RGNX: 228%
Market capitalization -- FDMT: $181.13M vs. RGNX: $417.84M
FDMT [@Biotechnology] is valued at $181.13M. RGNX’s [@Biotechnology] market capitalization is $417.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 5 bullish, 3 bearish.
  • RGNX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than RGNX.

Price Growth

FDMT (@Biotechnology) experienced а +5.39% price change this week, while RGNX (@Biotechnology) price change was -7.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

FDMT is expected to report earnings on Aug 07, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($418M) has a higher market cap than FDMT($181M). RGNX YTD gains are higher at: 7.762 vs. FDMT (-29.803). FDMT (-196.46M) and RGNX (-198.23M) have comparable annual earnings (EBITDA) . FDMT has more cash in the bank: 321M vs. RGNX (235M). FDMT has less debt than RGNX: FDMT (23.9M) vs RGNX (82M). RGNX has higher revenues than FDMT: RGNX (83.3M) vs FDMT (23K).
FDMTRGNXFDMT / RGNX
Capitalization181M418M43%
EBITDA-196.46M-198.23M99%
Gain YTD-29.8037.762-384%
P/E RatioN/AN/A-
Revenue23K83.3M0%
Total Cash321M235M137%
Total Debt23.9M82M29%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRGNX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNPIX77.50N/A
N/A
Consumer Staples UltraSector ProFund Inv
OLVAX20.10N/A
N/A
JPMorgan Large Cap Value A
NELCX51.06N/A
N/A
Nuveen Equity Long/Short C
GGGPX40.49N/A
N/A
Goldman Sachs Large Cap Equity P
DTCYX19.37N/A
N/A
BNY Mellon Sust US Equity Y

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with STOK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.09%
STOK - FDMT
45%
Loosely correlated
-0.73%
IMNM - FDMT
44%
Loosely correlated
+1.16%
IDYA - FDMT
43%
Loosely correlated
-0.09%
VTYX - FDMT
42%
Loosely correlated
+13.07%
RGNX - FDMT
41%
Loosely correlated
-17.36%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-17.36%
DNLI - RGNX
55%
Loosely correlated
-1.35%
BEAM - RGNX
53%
Loosely correlated
-0.87%
ARWR - RGNX
52%
Loosely correlated
-1.73%
XNCR - RGNX
51%
Loosely correlated
+0.22%
VYGR - RGNX
50%
Loosely correlated
-0.75%
More